CIK 722104

SAVIENT PHARMACEUTICALS INC

CIK 0000722104 · EDGAR ↗

cleanelevatedtriggeredno dataplanned

75.6

composite · 3 signals · ELEVATED

Every card below shows the score and the exact filing data it was computed from — no unexplained numbers. Some signals (P-02, P-03, P-08, P-09, P-10, P-11) pull live documents from SEC EDGAR the first time you view this company; a few of those (P-03, P-10, P-11) use AI to read the filing text, but every AI claim must quote the actual document verbatim or it's discarded — never a guess.

Chat with this filing →

Ask follow-up questions about the latest 10-K, with citations verified against the actual text. No account needed.

Investigation memo — generate one →

Run the bounded investigation agent — reads this company's signals and writes a short, cited summary.

Signals

P-13 · FY 2012-12-31 · ELEVATED100.0

Zombie / distress

Interest coverage -4.98x below 1.0

trend: flat

Trend

Source: 10-K on SEC.gov (filed 2013-04-01) ↗

Evidence — inputs and thresholds

{
  "icr_by_year": {
    "2012-12-31": -4.985,
    "2011-12-31": -7.057,
    "2010-12-31": null,
    "2009-12-31": null
  },
  "consecutive_years_below_1": 2,
  "altman_z_double_prime": -17.665,
  "definitions": {
    "zombie": "ICR<1 for 3+ consecutive FYs (BIS 2018)",
    "z_distress": "<1.1 distress, 1.1-2.6 gray, >2.6 safe"
  },
  "inputs": {
    "ebit_t": -119098000,
    "interest_expense_t": 23892000
  },
  "stale": false,
  "latest_filing_period": "2012-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/0001193125-13-136648-index.htm",
    "form": "10-K",
    "filed": "2013-04-01"
  }
}

P-01 · FY 2012-12-31 · CLEAN0.0

Earnings quality

Beneish M-Score -6.00 — no manipulation profile

trend: flat

Trend

Source: 10-K on SEC.gov (filed 2013-04-01) ↗

Evidence — inputs and thresholds

{
  "m_score": -5.997,
  "threshold": -1.78,
  "ratios": {
    "DSRI": 0.486,
    "GMI": 1,
    "AQI": 1.951,
    "SGI": 1.884,
    "DEPI": 1.784,
    "SGAI": 0.517,
    "LVGI": 13.999,
    "TATA": -0.03
  },
  "defaulted_to_neutral": [
    "GMI"
  ],
  "sloan_accruals": -0.0226,
  "inputs": {
    "revenue_t": 18023000,
    "revenue_t1": 9565000,
    "total_assets_t": 119206000,
    "net_income_t": -118312000,
    "cfo_t": -114745000
  },
  "stale": false,
  "latest_filing_period": "2012-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/0001193125-13-136648-index.htm",
    "form": "10-K",
    "filed": "2013-04-01"
  }
}

P-12 · FY 2012-12-31 · CLEAN17.2

Restatement predictor

F-Score 0.52 — at or below the population base rate

trend: flat

Trend

Source: 10-K on SEC.gov (filed 2013-04-01) ↗

Evidence — inputs and thresholds

{
  "f_score": 0.517,
  "probability": 0.00191,
  "components": {
    "rsst": -0.0226,
    "drec": -0.0025,
    "dinv": -0.0417,
    "soft": 0.5606,
    "dcs": 0.9257,
    "droa": -0.4749,
    "issue": 0
  },
  "model": "Dechow et al. 2011, Model 1 (simplified RSST)",
  "thresholds": {
    "elevated": 1,
    "triggered": 1.85
  },
  "stale": false,
  "latest_filing_period": "2012-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/0001193125-13-136648-index.htm",
    "form": "10-K",
    "filed": "2013-04-01"
  }
}